Owner Scorecard


← All companies ← QCRH Manual QLYS → ← PROK Biotechnology QGEN →

QDEL, QuidelOrtho

Biotechnology consumer brand UnprofitableDistress / turnaroundCyclical

Our global infrastructure and commercial reach support our customers across more than 140 countries and territories with quality diagnostics, a broad test portfolio and market-leading service.

We generate our revenue in the following business units: Labs, Transfusion Medicine (Immunohematology and Donor Screening product categories), Point of Care and Molecular Diagnostics.

Specifically, we are winding-down the VIP platform and microplate assays, which are only sold in the U.S. and have a lower growth and margin profile.

Latest annual: FY2025 10-K
QDEL · QuidelOrtho
I

The business

What it sells, where the money comes from, the kind of company it is.

Revenue · FY2025
$2.7B
−1.9% YoY · 10% 5-yr CAGR
Vital signs · TTM, with 5-yr average
Revenue $2.7B 5-yr avg $2.7B
Operating margin −37.0% 5-yr avg −4.1%
ROIC −17% 5-yr avg −21%
Owner-earnings margin −6% 5-yr avg 12%
Free cash flow margin −6% 5-yr avg 10%

Next report By 8/7 · the 10-Q for the quarter ended late June · due within 40 days of period end · has filed ~39 days after · the wire records it on arrival

The business in brief

read the 10-K →

What this business is and what moves its needle, from its own SEC filings.

Situation
Unprofitable. No sustained operating profit across the record; an earnings multiple has nothing to rest on. What the record does show is revenue, the gross-margin trajectory, and the burn against the cash on hand. Distress / turnaround. Thin interest coverage, or operating cash burned against real debt, across the record. The balance sheet carries this situation; the debt schedule sets the clock. Cyclical. Margins collapse and recover repeatedly across the record; a single year, good or bad, misstates the through-cycle earning power.
What moves the needle
Operating margin has run about 15% through the cycle, a solid margin the cost base and competition set as much as the price does. The operating margin has swung widely — from −70% to 64% over the years — so the through-cycle figure carries more than any single year, and the worst year more than the best. Inventory runs near 19% of sales, so how fast it turns back into cash — and the risk of writing it down when demand softens — sits alongside the margin. Read this kind of business on the pipeline against the patent cliff, and pricing. On its own account, the filing leans hardest on pricing power & competition, set against the numbers in what the filing emphasizes, below.

Every line is arithmetic on the company's filings, shown in full in the sections below.

Where the money comes from

read the 10-K →

47% of revenue comes from outside the United States.

Revenue by geography, FY2025
  • Domestic53%$1.4B
  • Foreign47%$1.3B

From the segment footnote of the company's own 10-K. Shares are of total revenue; the profit bar shows each segment's share of segment operating profit, before unallocated corporate costs.

II

The record

Ten years of arithmetic, read across the cycle.

The record, 2020–2025

realized figures from each filing · older years to the left
2020’202021’212022’222023’232024’242025’25TTMTTMMar 2026
Income statement
$1.7B$1.7B$3.3B$3.0B$2.8B$2.7B$2.7BRevenueRevenue
11%14%19%25%28%27%29%SG&A / revenueSG&A/rev
5%6%6%8%8%7%7%R&D / revenueR&D/rev
$1.1B$906M$844M$139M($2.0B)($919M)($984M)Operating incomeOp. inc.
63.8%53.3%25.8%4.6%−70.5%−33.7%−37.0%Operating marginOp. mgn
$1.0B$900M$736M($29M)($2.1B)($1.1B)Pretax incomePretax
$810M$704M$549M($10M)($2.1B)($1.1B)($1.2B)Net incomeNet inc.
22%22%25%Effective tax rateTax rate
Cash flow & returns
$630M$806M$885M$280M$83M$105M$7MOperating cash flowOp. cash
$49M$53M$284M$457M$453M$442M$448MDepreciationDeprec.
($250M)$24M$5M($219M)$1.6B$749M$725MWorking capital & otherWC & other
$65M$293M$141M$209M$195M$188M$166MCapexCapex
3.9%17.2%4.3%7.0%7.0%6.9%6.2%Capex / revenueCapex/rev
$581M$753M$744M$71M($112M)($83M)($159M)Owner earningsOwner earn.
35.0%44.3%22.8%2.4%−4.0%−3.0%−6.0%Owner earnings marginOE mgn
$565M$513M$744M$71M($112M)($83M)($159M)Free cash flowFCF
34.0%30.2%22.8%2.4%−4.0%−3.0%−6.0%Free cash flow marginFCF mgn
$0$0$1.5B$0$0$0AcquisitionsAcquis.
$44M$104M$74M$7M$0$0BuybacksBuybacks
($63M)($320M)($1.6B)($188M)($150M)($193M)Investing cash flowInv. cash
($130M)($173M)$252M($266M)$49M$156MFinancing cash flowFin. cash
$1M($400K)($2M)($1M)($3M)$3MExchange-rate effectFX
$437M$313M($509M)($174M)($21M)$71MChange in cashΔ cash
-27%-16%-17%ROICROIC
-0%-69%-59%-65%Return on equityROE
−0%−69%−59%−65%Retained to equityRetained/eq
Balance sheet
$490M$866M$366M$175M$98M$170M$140MCash & investmentsCash+inv
$378M$454M$303M$282M$417M$360MReceivablesReceiv.
$199M$524M$578M$534M$578M$612MInventoryInvent.
$102M$283M$295M$246M$279M$244MAccounts payablePayables
$475M$695M$586M$570M$715M$728MOperating working capitalOper. WC
$1.4B$1.6B$1.3B$1.2B$1.4B$1.4BCurrent assetsCur. assets
$324M$1.0B$834M$999M$966M$962MCurrent liabilitiesCur. liab.
4.5×1.6×1.6×1.2×1.5×1.4×Current ratioCurr. ratio
$349M$1.3B$1.4B$1.4B$1.4BNet PP&ENet PP&E
$337M$2.5B$2.5B$650M$0$0GoodwillGoodwill
$2.4B$8.9B$8.6B$6.4B$5.8B$5.6BTotal assetsAssets
$700K$2.9B$2.6B$2.8B$2.9B$2.9BTotal debtDebt
($866M)$2.5B$2.4B$2.7B$2.7B$2.8BNet debt / (cash)Net debt
11.1×0.9×-12.0×-5.2×-5.2×Interest coverageInt. cov.
$5.0B$3.0B$1.9B$1.9BShareholders’ equityEquity
1.3%1.5%1.5%1.7%1.5%1.7%1.7%Stock comp / revenueSBC/rev
$1.8B$701M$701MGoodwill written downGW imp.
Per share
43.6M42.9M57.4M66.8M67.2M67.8M68.2MShares out (diluted)Shares
$38.11$39.59$56.90$44.88$41.41$40.27$38.96Revenue / shareRev/sh
$18.58$16.41$9.56$-0.15$-30.54$-16.69$-17.76EPS (diluted)EPS
$13.32$17.56$12.97$1.06$-1.67$-1.22$-2.34Owner earnings / shareOE/sh
$12.95$11.96$12.97$1.06$-1.67$-1.22$-2.34Free cash flow / shareFCF/sh
$1.49$6.83$2.45$3.13$2.90$2.78$2.43Cap. spending / shareCapex/sh
$74.94$44.41$28.33$27.15Book value / shareBVPS
Per-share growththe realized rate an owner's share compounded
5-yr5-yr
Revenue / share+1.1%/yr+1.1%/yr
Capital spending / share+13.3%/yr+13.3%/yr
Book value / share−38.5%/yr (2-yr)−38.5%/yr (2-yr)

Where the cash went

ReinvestBuybacksDividendsAcquisitionsRetainedBeyond op. cash

Each year's outlays against its operating cash: the mix, and how it drifts. The hatched cap is spending beyond that year's operating cash — financed from the balance sheet or borrowing, not operations.

FY2020FY2025

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2025 the business turned a $1.1B loss into ($83M) of owner earnings: more cash than the profit line showed, after the non-cash charges and the capital it put back in.

FY2025FY2024FY2023FY2022FY2021
Reported net income($1.1B)($2.1B)($10M)$549M$704M
Depreciation & amortizationnon-cash charge added back+$442M+$453M+$457M+$284M+$53M
Stock-based compensationreal costnon-cash, but a real cost+$46M+$42M+$52M+$48M+$25M
Working capital & othertiming of cash in and out, other non-cash items+$749M+$1.6B−$219M+$5M+$24M
Cash from operations$105M$83M$280M$885M$806M
Maintenance capital expenditurethe spending needed just to hold position and volume−$188M−$195M−$209M−$141M−$53M
Owner earnings($83M)($112M)$71M$744M$753M
Growth capital expenditurediscretionary; spent to get bigger, not to stand still−$240M
Free cash flow($83M)($112M)$71M$744M$513M
Owner-earnings marginowner earnings ÷ revenue-3%-4%2%23%44%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $46M), owner earnings is nearer ($129M).

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

III

Quality & stewardship

Returns, the balance sheet, capital allocation, and pay.

Owner’s Scorecard

FY2025 10-K · source on SEC EDGAR →

Will it survive?

  • Does not cover its interest
    Operating income ($919M) ÷ interest expense $178M
    What this means

    A full year of operating profit didn't cover the interest bill. This is the zombie zone: the business depends on refinancing, asset sales, or forbearance to service its debt.

  • Net debt against an operating loss
    Cash $170M − debt $2.9B
    What this means

    Netting $170M of cash and short-term investments against $2.9B of debt leaves $2.7B owed, with no operating profit this year to measure it against — understand that combination before anything else about the company. Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.

  • Not enough data
    What this means

    The filing data didn't include the inputs for this check.

Is it a good business?

  • Below average
    NOPAT ($726M) ÷ invested capital $4.6B (debt + equity − cash)
    Industry peers: median 10%
    What this means

    The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.

  • Solid through the cycle
    6-yr median margin, range -4%–44%; latest ($83M) = operating cash $105M − maintenance capex $188M
    Industry peers: median 18%
    What this means

    What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's -3% of revenue this year, a 13% median across 6 years. Treating stock comp as the real expense it is (less $46M of SBC) leaves ($129M).

  • Loss, but cash-generative
    Net income ($1.1B) · cash from operations $105M
    What this means

    The company reported a net loss, so a conversion ratio isn't meaningful. What matters then is whether operations still threw off cash, here, they did.

How is the cash used?

  • No surplus to allocate
    What this means

    The business didn't generate positive Owner Earnings this year, so any distributions came from the balance sheet or borrowing, not from operations.

  • Investing or harvesting? 0.43×
    Harvesting
    Capex $188M ÷ depreciation $442M
    What this means

    Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

The promise and the pay packet

  • Is the buyback buying ownership, or mopping up? 1.7%
    The count is rising
    Stock compensation $46M (fiscal 2025), 1.7% of revenue · no repurchases · diluted shares +18.1% since 2022
    What this means

    Stock handed to employees is a real cost paid in the owner's own currency: it is charged against profit, but the shares it creates are permanent. Many companies repurchase stock at the same time, which looks like a return of capital and often is not — if the count barely moves, the cash merely cancelled the pay packet and bought the owner nothing. The three states worth telling apart are a count genuinely shrinking, a count standing still despite large repurchases, and a count rising because the issuance was never offset at all.

Graham’s defensive tests · 1 of 5 met

Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.

  • Adequate size Pass
    Revenue ≥ $2B · $2.7B
    What this means

    Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.

  • Strong liquidity Miss
    Current ratio ≥ 2× · 1.50×
    What this means

    Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.

  • Conservative debt Miss
    Debt ≤ working capital · $2.9B vs $481M WC
    What this means

    Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.

  • Earnings stability Miss
    A profit every year (6-yr record) · 3 loss years
    What this means

    Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.

  • Dividend record
    Uninterrupted dividends · no dividend line tagged in the data
    What this means

    An unbroken dividend was Graham's mark of durability. This record carries no dividends-paid line in any year — common for partnerships, whose distributions file under tags the chain doesn't read — so the criterion is withheld rather than judged on silence.

  • Earnings growth Miss
    Earnings +33% over the record · −255%
    What this means

    At least a third more earnings than a decade ago, averaging three years at each end. Net income (not per-share), so stock splits don't distort it, buybacks and dilution show up in the share-count line instead.

  • Moderate price
    P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
    What this means

    Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $-15.61/share (latest year $-16.60), the averaged base the calculator's gate runs on, and book value is $28.16/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.

Durability & moat, 2020–2025

Whether the record’s returns held, and what the capital reinvested earned.

  • Profitable years 3 of 6
    What this means

    Lost money in 3 year(s), look at what happened there before trusting the average.

  • Return on capital ≥ 15% 0 of 3 yrs
    What this means

    A moat shows up as a high return on invested capital that holds year after year, not one good vintage.

  • Operating margin 48% → −33% (3-yr avg ends)
    What this means

    Through the cycle the operating margin slipped — about 48% early to −33% lately, median 5% — competition or costs are biting in.

  • Reinvestment, incremental ROIC returns capital
    What this means

    The capital base barely grew: this business returns cash through dividends and buybacks rather than reinvesting. Judge it on the cash returned, not on compounding.

  • Worst year 2024 · −70.5% op. margin
    What this means

    Operations went underwater in 2024, understand why before trusting the good years.

  • Share count +9.2%/yr
    What this means

    The share count is rising, dilution works against you on a per-share basis.

All figures as filed; the source filing is linked above.

Current Position

as of the latest quarter, Mar 29, 2026

Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.

Current assets$1.4B
  • Cash & short-term investments$140M
  • Receivables$360M
  • Inventory$612M
  • Other current assets$265M
Current liabilities$962M
  • Debt due within a year$228M
  • Accounts payable$244M
  • Other current liabilities$491M
Current ratio1.43×all current assets ÷ what's due · Graham looked for 2×
Quick ratio0.80×stricter: inventory excluded
Cash ratio0.15×strictest: cash alone against what's due
Working capital$415Mthe cushion left after near-term bills
Debt due this year vs. cash$228M due · $140M cash cash alone won't cover the maturities; it leans on refinancing or operating cash · both figures from the Mar 29, 2026 balance sheet
Revenue, latest quarter vs. a year ago−10.5%the freshest read on whether the business is still growing
Current ratio, recent quarters1.4× → 1.4×
Deeper floors
Tangible book value($669M)equity stripped of goodwill & intangibles
Net current asset value($2.4B)Graham's net-net: current assets less all liabilities
Debt incl. operating leases$3.1B$187M of it operating leases
Deferred revenue$50Mcustomer cash collected before delivery; operating float

From the company's latest filing.

How the cash was used, 2020–2025

Over the record, the business generated $2.8B of operating cash; how management split it reads as a balanced allocator, splitting cash between the business, owners, and the balance sheet.

  • Reinvested$1.1B · 39%
  • Buybacks$229M · 8%
  • Retained (debt / cash)$1.5B · 53%
  • Returned to owners$229M

    12% of the owner earnings the business produced over the span, $0 as dividends and $229M as buybacks.

  • Average price paid for buybacks

    Buybacks ran $229M over the span, but the filings don't tag the share count needed to deduce the average price paid.

  • Net change in share count56.4%

    The diluted count rose from 44M to 68M: issuance (stock pay, deals) outran any buybacks, so owners were diluted on net.

  • Dividend record

    No dividend line was reported in the filing data over the span; the record here neither confirms nor rules out a payout.

Buybacks are gross of stock issued to staff; the share-count line above is the net of that, the figure that decides whether owners gained. The average price paid blends a year of purchases (and any accelerated repurchase), so it is close, not exact. The record of where the cash went and on what terms.

Acquisitions & goodwill

from the balance sheet & the 6-year cash-flow record

Goodwill grows only when a company acquires and falls only when it concedes it overpaid. The size of that bet, the cash put into buying rather than building, and how much has already been written off.

Goodwill & intangibles$2.6B44% of all assets; the premium carried on the balance sheet for businesses acquired
Against book equity0%goodwill is this share of book equity; the rest is the company’s own retained and paid-in capital
Cash spent acquiring$1.5Bover 6 years buying other businesses, against $1.1B of capital spent building

$2.5B written down across 2 years (2024, 2025): goodwill the company has already conceded it overpaid for, charged against earnings. A write-down costs no cash (the cash went out when the deal was signed), but it is management marking its own past judgment to market.

Goodwill, acquired intangibles and equity from the latest balance sheet; acquisition spend and write-downs summed across the 6-year record, from the company's own filings.

Management, ownership & pay

read the proxy →

From the proxy: how much of the business the people running it own, and how they are paid.

  • Insider ownership<1%

    The stake all directors and executive officers hold together, per the 2026 proxy: skin in the game, the first thing Munger reads.

  • CEO pay ratio154:1

    What the chief earns for every dollar the median employee makes, per the 2026 proxy. A high ratio alone settles nothing; some businesses are genuinely top-heavy in scarce skill. A runaway figure is where Buffett starts asking whether the board is doing its job.

  • Stock-based compensation$46M

    The slice of the business handed to employees in shares in fiscal 2025, 1.7% of revenue. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.

What an owner would ask, FY2025

read the 10-K →
  • Which reported numbers are a judgment call?
    Management names Income taxes, Inventory as critical estimates

    each rests partly on management's judgment; the filing's note sets out the assumptionsverify →

The questions the record and the charts do not answer on their own; each carries the figure and the place to look.

Peers, Biotechnology

The same industry, side by side on owner economics. Each column names the period it is read over, and a median resting on fewer than three years carries that count beside it; the group median at the foot is the line to read each figure against.

CompanyRevenuelatest FY, USDGross marginmedian over the recordOp. marginmedian over the recordROICmedian over the recordOwner earn. marginmedian over the record
IDXXIDEXX Laboratories Inc.$4.3B58%26.2%57%18%
BNTXBioNTech SE American Depositary Share$3.3B84%-42.2%-10%4%
NBIXNeurocrine$2.9B98%13.3%10%22%
QDELQuidelOrtho$2.7B15.2%-21%2y13%
EXELExelixis Inc.$2.3B96%23.9%11%34%
QGENQiagen N.V.$2.1B65%19.2%7%19%
MRNAModerna Inc.$1.9B55%4y-121.9%-35%-56%
LNTHLantheus Holdings$1.5B51%17.2%24%17%
Group median16.2%8%17%
IV

The price

What a price has to assume.

What the price implies

reverse-DCF

Type today's close and see the owner-earnings growth you'd have to believe to justify it, beside what QuidelOrtho has delivered.

QuidelOrtho’s latest year shows negative owner earnings, a cyclical trough. So the tool opens on the through-cycle base, the cash it would earn at rest; clear the toggle below to read the latest year exactly as reported.

$

Through the cycle, QuidelOrtho earns about $343M on its 12.6% median owner-earnings margin. This year’s −3.0% margin runs below that; the reported figure may understate a lean year. Normalize, below, values the price on that through-cycle figure rather than the latest year.

Base

The assumptions

9.0% = the 4.68% 10-year Treasury (Jul 30, 2026) + 4.32 points of equity premium. The rate you require is yours to set.

Enter a price above to run it.

Implied by the price
Owner-earnings growth, delivered
Owner-earnings yield
P/E (3-yr earnings ’23–’25)
P/B
Graham’s price gate

Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.

Against a high-grade bond: Graham’s yardstick bond yield%

Prefilled with the 10-year Treasury (4.68%, as of Jul 30, 2026). Edit it for today’s exact figure, or a AAA corporate yield.

Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.

Owner earnings ($159M) on 68M shares outstanding, per the 10-Q cover, as of 2026-04-28; net debt $2.8B. The base opens on the through-cycle figure (the latest year sits off the record’s own median, and Graham’s averaging cuts both ways); clear Normalize to use the year as filed. Net of stock comp treats option pay as the expense it is. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.

Cite: Owner Scorecard, "QuidelOrtho (QDEL), the owner's record," https://ownerscorecard.com/c/QDEL, data as of 2026-07-18.

Manual order: ← QCRH its page in the Manual QLYS →

Industry order: ← PROK the Biotechnology chapter QGEN →